# Seroprevalence of Antibodies to Surface Antigens and Toxins of Clostridioides Difficile

> **NCT05192148** · NA · UNKNOWN · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 840 (estimated)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **OTHER:** Patients

## Key facts

- **NCT ID:** NCT05192148
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-30
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 840 (ESTIMATED)
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05192148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05192148, "Seroprevalence of Antibodies to Surface Antigens and Toxins of Clostridioides Difficile". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05192148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*